drugset / Trial / NCT01199289
A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if AMG 827 is effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.
Timeline
- Start
- 2010-10-04
- Primary completion
- 2011-12-21
- Completion
- 2011-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brodalumab | Monoclonal antibody | 140 mg | Subcutaneous |
| Subject | Brodalumab | Monoclonal antibody | 210 mg | Subcutaneous |
| Subject | Brodalumab | Monoclonal antibody | 280 mg | Subcutaneous |